Top compounds associated with response to CLN3


Feature Type Standardized
Nominal ANOVA
mRNA BRD1812 CTRPv2 pan-cancer AAC -0.015 0.7
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.015 0.7
mRNA AZD0530 CTRPv2 pan-cancer AAC -0.015 0.7
mRNA BRD-K27188169 CTRPv2 pan-cancer AAC 0.021 0.7
mRNA thalidomide CTRPv2 pan-cancer AAC 0.023 0.7
mRNA SMER-3 CTRPv2 pan-cancer AAC 0.016 0.7
mRNA myriocin CTRPv2 pan-cancer AAC -0.031 0.7
mRNA fulvestrant CTRPv2 pan-cancer AAC -0.03 0.7
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.02 0.7
mRNA JW-480 CTRPv2 pan-cancer AAC 0.015 0.7
Download CSV